Fedeli A - Search Results

1

Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.

Rossi D, Alessandroni P, Catalano V, Giordani P, Fedeli SL, Fedeli A, Baldelli AM, Casadei V, Ceccolini M, Catalano G. Rossi D, et al. Among authors: fedeli sl, fedeli a. Clin Breast Cancer. 2007 Dec;7(11):857-60. doi: 10.3816/CBC.2007.n.050. Clin Breast Cancer. 2007. PMID: 18269775 Clinical Trial.

2

Weekly docetaxel as second-line therapy in non-small cell lung cancer: a phase II study.

Rossi D, Graziano F, Ugolini M, Dennetta D, Alessandroni P, Catalano V, Giordani P, Fedeli SL, Fedeli A, Catalano G. Rossi D, et al. Among authors: fedeli sl, fedeli a. Tumori. 2004 Jan-Feb;90(1):50-3. doi: 10.1177/030089160409000112. Tumori. 2004. PMID: 15143972 Clinical Trial.

3

A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.

Rossi D, Catalano V, Alessandroni P, Fedeli A, Fedeli SL, Giordani P, Baldelli AM, Casadei V, Ceccolini M, Ugolini M, Dennetta D, Catalano G. Rossi D, et al. Among authors: fedeli sl, fedeli a. Clin Lung Cancer. 2007 May;8(6):382-5. doi: 10.3816/clc.2007.n.019. Clin Lung Cancer. 2007. PMID: 17562239 Clinical Trial.

4

Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.

Rossi D, Graziano F, Luzi Fedeli S, Fedeli A, Alessandroni P, Catalano V, Giordani P, Testa E, Catalano G. Rossi D, et al. Among authors: fedeli a. Minerva Med. 2002 Aug;93(4):303-7. Minerva Med. 2002. PMID: 12207200 Clinical Trial.

5

A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.

Rossi D, Graziano F, Catalano V, Giordani P, Fedeli SL, Alessandroni P, Fedeli A, Dennetta D, Ugolini M, Catalano G. Rossi D, et al. Among authors: fedeli sl, fedeli a. Anticancer Res. 2002 Sep-Oct;22(5):3087-92. Anticancer Res. 2002. PMID: 12530048 Clinical Trial.

6

Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.

Cascinu S, Fedeli A, Fedeli SL, Catalano G. Cascinu S, et al. Among authors: fedeli sl, fedeli a. Ann Oncol. 1992 Jun;3(6):489-91. doi: 10.1093/oxfordjournals.annonc.a058244. Ann Oncol. 1992. PMID: 1498068 Clinical Trial.

7

Treatment of elderly advanced gastric cancer patients with 5-fluorouracil and leucovorin combination.

Cascinu S, Fedeli A, Luzi Fedeli S, Catalano G. Cascinu S, et al. Among authors: fedeli a. J Chemother. 1992 Jun;4(3):185-8. doi: 10.1080/1120009x.1992.11739162. J Chemother. 1992. PMID: 1517814 Clinical Trial.

8

Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil.

Cascinu S, Fedeli A, Fedeli SL, Catalano G. Cascinu S, et al. Among authors: fedeli sl, fedeli a. Eur J Cancer. 1992;28(2-3):482-3. doi: 10.1016/s0959-8049(05)80082-6. Eur J Cancer. 1992. PMID: 1591068

9

Gastric metastases from breast cancer: a case report.

Cascinu S, Luzi Fedeli S, Fedeli A, Catalano G. Cascinu S, et al. Among authors: fedeli a. Tumori. 1989 Apr 30;75(2):150-1. doi: 10.1177/030089168907500214. Tumori. 1989. PMID: 2741221

10

Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.

Cascinu S, Fedeli A, Catalano G. Cascinu S, et al. Among authors: fedeli a. Cancer Chemother Pharmacol. 1994;34(1):72-4. doi: 10.1007/BF00686115. Cancer Chemother Pharmacol. 1994. PMID: 8174205 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters